USX:MBIO - Mustang Bio Inc Mustang Bio Inc
Sector: Health Care, Industry: Biotechnology
Next Earnings: 22 Mar 2022
Add to Watchlist
   
Add Alert 


Yahoo Finance

USD 2.02    +0.020 (+1%)
Show Basic Chart | 3M    6M    1Y    3Y    5Y          

30 Nov 2021


Loading...
Loading...
Loading...

General

CEO: Mr. Michael S. Weiss Esq.

IPO: 2017-08-22

Headquarters: US

Employees: 62

Homepage

Description

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on the acquisition, development, and commercialization of novel cancer immunotherapy products designed to utilize the power of the patient's own immune system to eliminate cancer cells. The products under development are - CD123, CD20, and CS1.